These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 32394096)
1. Measurement Strategies for Evidence-Based Antidepressants for Posttraumatic Stress Disorder Delivery: Trends and Associations with Patient-Reported Outcomes. Shiner B; Leonard C; Gui J; Cornelius S; Gradus JL; Schnurr PP; Watts BV Adm Policy Ment Health; 2021 Jan; 48(1):70-87. PubMed ID: 32394096 [TBL] [Abstract][Full Text] [Related]
2. Measurement Strategies for Evidence-Based Psychotherapy for Posttraumatic Stress Disorder Delivery: Trends and Associations with Patient-Reported Outcomes. Shiner B; Westgate CL; Gui J; Cornelius S; Maguen SE; Watts BV; Schnurr PP Adm Policy Ment Health; 2020 May; 47(3):451-467. PubMed ID: 31853686 [TBL] [Abstract][Full Text] [Related]
3. Prescribing trends in veterans with posttraumatic stress disorder. Bernardy NC; Lund BC; Alexander B; Friedman MJ J Clin Psychiatry; 2012 Mar; 73(3):297-303. PubMed ID: 22490256 [TBL] [Abstract][Full Text] [Related]
4. Gender differences in prescribing among veterans diagnosed with posttraumatic stress disorder. Bernardy NC; Lund BC; Alexander B; Jenkyn AB; Schnurr PP; Friedman MJ J Gen Intern Med; 2013 Jul; 28 Suppl 2(Suppl 2):S542-8. PubMed ID: 23807063 [TBL] [Abstract][Full Text] [Related]
5. Gender differences in medication prescribing patterns for veterans with posttraumatic stress disorder: A 10-year follow-up study. Hadlandsmyth K; Bernardy NC; Lund BC J Trauma Stress; 2022 Dec; 35(6):1586-1597. PubMed ID: 35797242 [TBL] [Abstract][Full Text] [Related]
6. Correlates of Nonimprovement to Pharmacotherapy for Chronic, Antidepressant-Resistant, Military Service-Related Posttraumatic Stress Disorder: Insights From the Veterans Affairs Cooperative Study No. 504. Byrne SP; Krystal JH; Rosenheck RA; Vessicchio J; Pietrzak RH; J Clin Psychopharmacol; 2017 Dec; 37(6):717-721. PubMed ID: 28945664 [TBL] [Abstract][Full Text] [Related]
7. Cultivating change door to door: Educational outreach to improve prescribing practices in rural veterans with posttraumatic stress disorder. Montaño M; Bernardy NC; Sherrieb K Subst Abus; 2017; 38(2):129-134. PubMed ID: 28277828 [TBL] [Abstract][Full Text] [Related]
8. Does comorbid chronic pain affect posttraumatic stress disorder diagnosis and treatment? Outcomes of posttraumatic stress disorder screening in Department of Veterans Affairs primary care. Outcalt SD; Hoen HM; Yu Z; Franks TM; Krebs EE J Rehabil Res Dev; 2016; 53(1):37-44. PubMed ID: 27005596 [TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. Friedman MJ; Marmar CR; Baker DG; Sikes CR; Farfel GM J Clin Psychiatry; 2007 May; 68(5):711-20. PubMed ID: 17503980 [TBL] [Abstract][Full Text] [Related]
10. Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program. Lockwood A; Steinke DT; Botts SR Ann Pharmacother; 2009 Jul; 43(7):1227-32. PubMed ID: 19584387 [TBL] [Abstract][Full Text] [Related]
11. The effects of age on initiation of mental health treatment after positive PTSD screens among Veterans Affairs primary care patients. Lu MW; Carlson KF; Duckart JP; Dobscha SK Gen Hosp Psychiatry; 2012; 34(6):654-9. PubMed ID: 22898446 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for older veterans diagnosed with posttraumatic stress disorder in Veterans Administration. Mohamed S; Rosenheck R Am J Geriatr Psychiatry; 2008 Oct; 16(10):804-12. PubMed ID: 18827226 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection. Mohamed S; Rosenheck RA J Clin Psychiatry; 2008 Jun; 69(6):959-65. PubMed ID: 18588361 [TBL] [Abstract][Full Text] [Related]
14. A Randomized, Placebo-Controlled Trial of Mirtazapine for the Treatment of Posttraumatic Stress Disorder in Veterans. Davis LL; Pilkinton P; Lin C; Parker P; Estes S; Bartolucci A J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33084254 [TBL] [Abstract][Full Text] [Related]
15. Medication Needs Vary for Terminally Ill Vietnam Era Veterans With and Without a Diagnosis of PTSD. Kelley-Cook E; Nguyen G; Lee S; Edwards TM; Sanchez-Reilly S Am J Hosp Palliat Care; 2016 Aug; 33(7):625-32. PubMed ID: 25991568 [TBL] [Abstract][Full Text] [Related]
16. Declining benzodiazepine use in veterans with posttraumatic stress disorder. Lund BC; Bernardy NC; Alexander B; Friedman MJ J Clin Psychiatry; 2012 Mar; 73(3):292-6. PubMed ID: 22152399 [TBL] [Abstract][Full Text] [Related]
17. Health care utilization and its costs for depressed veterans with and without comorbid PTSD symptoms. Chan D; Cheadle AD; Reiber G; Unützer J; Chaney EF Psychiatr Serv; 2009 Dec; 60(12):1612-7. PubMed ID: 19952151 [TBL] [Abstract][Full Text] [Related]
18. Off-Label Prescribing of Second-Generation Antipsychotics to Elderly Veterans with Posttraumatic Stress Disorder and Dementia. Semla TP; Lee A; Gurrera R; Bajor L; Li M; Miller DR; Smith EG; Wang C; Wan Y; Kazis LE; Bauer MS J Am Geriatr Soc; 2017 Aug; 65(8):1789-1795. PubMed ID: 28369688 [TBL] [Abstract][Full Text] [Related]
19. Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates. Bauer MS; Lee A; Li M; Bajor L; Rasmusson A; Kazis LE Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):77-86. PubMed ID: 23996688 [TBL] [Abstract][Full Text] [Related]
20. Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. Bounthavong M; Lau MK; Popish SJ; Kay CL; Wells DL; Himstreet JE; Harvey MA; Christopher MLD Subst Abus; 2020; 41(1):101-109. PubMed ID: 30870137 [No Abstract] [Full Text] [Related] [Next] [New Search]